Hengtong(SH:600226) Xin Lang Cai Jing·2025-10-21 02:11Core Viewpoint - Hengtong Holdings has shown significant stock performance with a year-to-date increase of 72.55%, despite a recent decline of 4.76% over the past five trading days [1] Financial Performance - For the first half of 2025, Hengtong Holdings achieved a revenue of 818 million yuan, representing a year-on-year growth of 45.80%, and a net profit attributable to shareholders of 127 million yuan, up 8.91% year-on-year [2] Stock Market Activity - As of October 21, Hengtong Holdings' stock price was 4.40 yuan per share, with a market capitalization of 13.087 billion yuan. The stock experienced a trading volume of 63.78 million yuan and a turnover rate of 0.49% [1] - The company has seen a net inflow of main funds amounting to 5.1236 million yuan, with significant buying activity from large orders [1] Shareholder Information - As of June 30, the number of shareholders for Hengtong Holdings was 34,200, an increase of 0.64% from the previous period, with an average of 86,876 circulating shares per shareholder, a decrease of 3.39% [2] Business Overview - Hengtong Holdings, established on May 11, 1999, and listed on November 16, 1999, is primarily engaged in the production and sales of biopesticides, veterinary drugs, feed additives, and related services. The main revenue sources are electrolytic copper foil (67.62%), electricity and steam (16.17%), and veterinary drugs (16.14%) [1][2] Dividend Information - Since its A-share listing, Hengtong Holdings has distributed a total of 709 million yuan in dividends, with no dividends paid in the last three years [3]